Health and Human Services Secretary Robert F. Kennedy Jr. said companies "came to the table" to avoid a patchwork of state ...

Luminopia, Inc., a digital health company pioneering a new class of treatments for neuro-visual disorders, today announced that the U.S. Food & Drug Administration (FDA) cleared its amblyopia ...

Fifth issued patent in the U.S. for QTORIN™ rapamycin with anticipated patent life extending into 2038QTORIN™ rapamycin has the potential to be ...